Teladoc Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 660.24 million compared to USD 611.4 million a year ago. Net loss was USD 57.07 million compared to USD 73.48 million a year ago. Basic loss per share from continuing operations was USD 0.35 compared to USD 0.45 a year ago.
For the nine months, sales was USD 1,941.89 million compared to USD 1,769.13 million a year ago. Net loss was USD 191.48 million compared to USD 9,849.46 million a year ago. Basic loss per share from continuing operations was USD 1.17 compared to USD 61.09 a year ago.